EisaiEisai Glossary Eisai Glossary

 Inovelon®/BANZEL®
 Eisai product names 
Generic name: rufinamide. Antiepileptic agent created by Novartis that possesses novel triazole derivative structure and extensive anticonvulsant effects. It is marketed in Europe, the United States and Japan as an adjunctive therapy for Lennox-Gastaut syndrome (LGS), one of the most severe and intractable forms of childhood-onset epilepsy. Sold under the name BANZEL® in the United States and Canada.




close


Copyright (C) Eisai Co., Ltd. All Rights Reserved.